Efficacy of Belimumab in Primary Sjögren’s Syndrome: A Systematic Review

https://www.sciencedirect.com/science/article/pii/S1699258X20300760?via%3Dihub https://www.ncbi.nlm.nih.gov/pubmed/32451263?dopt=Abstract TITLE: Efficacy of Belimumab in Primary Sjögren’s Syndrome: A Systematic Review. DESCRIPTION: Related Articles Efficacy of Belimumab in Primary Sjögren’s Syndrome: A Systematic Review. Reumatol Clin. 2020 May 22;: Authors: Álvarez-Rivas N, Sang-Park H, Díaz Del Campo P, Fernández-Castro M, Corominas H, Andreu JL, Navarro-Compán V Abstract OBJECTIVE: To evaluate the efficacy and […]

Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren’s syndrome

https://www.sciencedirect.com/science/article/pii/S1521694220300012?via%3Dihub https://www.ncbi.nlm.nih.gov/pubmed/32067925?dopt=Abstract TITLE: Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren’s syndrome. DESCRIPTION: Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren’s syndrome. Best Pract Res Clin Rheumatol. 2020 Feb 15;:101485 Authors: van den Hoogen LL, van Laar JM Abstract Targeted therapies using biological disease-modifying antirheumatic drugs (bDMARDs) and small molecule synthetic […]